| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 865.701 | 797.721 | 917.531 | 1.001.421 | 947.937 | 524.230 | 1.234.837 | 1.288.247 | 755.882 | 783.714 |
| Total Income - EUR | 884.342 | 870.295 | 999.978 | 976.041 | 953.962 | 686.518 | 1.421.329 | 1.362.365 | 924.028 | 1.044.144 |
| Total Expenses - EUR | 803.310 | 744.410 | 816.926 | 849.620 | 877.860 | 946.803 | 833.855 | 1.000.561 | 973.942 | 1.107.663 |
| Gross Profit/Loss - EUR | 81.033 | 125.885 | 183.052 | 126.421 | 76.102 | -260.286 | 587.474 | 361.804 | -49.914 | -63.519 |
| Net Profit/Loss - EUR | 67.829 | 105.372 | 146.399 | 119.475 | 69.356 | -263.034 | 577.885 | 319.440 | -49.914 | -63.519 |
| Employees | 11 | 10 | 10 | 10 | 6 | 6 | 4 | 6 | 6 | 6 |
Check the financial reports for the company - Profarma Holding S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.223.078 | 1.512.438 | 1.647.408 | 2.000.536 | 2.402.959 | 2.239.643 | 2.525.364 | 2.490.692 | 3.252.237 | 3.114.596 |
| Current Assets | 400.017 | 423.735 | 514.075 | 376.070 | 266.166 | 201.489 | 446.063 | 499.494 | 430.108 | 454.477 |
| Inventories | 110.980 | 174.118 | 332.963 | 253.195 | 101.864 | 70.923 | 240.181 | 336.532 | 165.537 | 179.635 |
| Receivables | 142.698 | 209.063 | 104.443 | 53.311 | 93.068 | 60.828 | 58.915 | 46.308 | 250.159 | 255.802 |
| Cash | 146.339 | 40.554 | 76.670 | 69.563 | 71.234 | 69.738 | 146.968 | 116.653 | 14.412 | 19.040 |
| Shareholders Funds | 886.561 | 1.062.885 | 1.178.790 | 1.273.804 | 1.294.184 | 981.958 | 1.500.297 | 1.681.635 | 1.762.089 | 1.705.091 |
| Social Capital | 114.736 | 113.566 | 111.644 | 109.595 | 107.472 | 105.435 | 103.097 | 103.417 | 103.103 | 102.527 |
| Debts | 737.538 | 874.283 | 983.688 | 1.103.856 | 1.374.942 | 1.479.324 | 1.471.615 | 1.309.126 | 1.921.354 | 1.865.075 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Profarma Holding S.r.l.